Abstract Submission for BOPA Symposium 2021

Delegates are invited to present results of their clinical and technical work as a poster with some selected as an oral presentation. The author/s should submit via the BOPA website by noon on Friday 16th July 2021.

Abstracts will be reviewed and marked by the BOPA Audit and Research Sub-Committee, and chosen authors will be invited to display their poster for the duration of the conference, with the posters achieving high scores selected for oral presentation.

Selected abstracts will be published in a supplement to the Journal of Oncology Pharmacy Practice (JOPP), providing authors with a citation in a peer reviewed journal. The winning presentation will receive a prize worth £2,000 to attend an international conference or pay towards research funding including open access publishing fees.

DEADLINE: Friday 16th July 2021

For further information and to submit your abstract, please go to https://www.bopa.org.uk/abstractsubmission-2021/

Late Breaking Abstracts: Abstracts relating to the Covid-19 pandemic will be considered for presentation by the research committee if completed work is submitted after the 16th July deadline. Please contact the A&R committee ([email protected]) to request a late submission relating to Covid-19.

This year the Audit and Research committee will be providing 1:1 support via appointment, we have four slots available in April. Please contact BOPA A&R ([email protected]) if you are interested in receiving this support.

Best wishes,

BOPA Audit and Research Sub-Committee

Latest News

By BOPA Committee on 22nd July 2024

REMINDER – 2024 Elections to the BOPA Executive Committee: Call for nomination of members

BOPA is looking for new Executive Committee members who are dedicated to furthering the association’s aims and who are willing, and able, to spend time helping run the organisation. Those…

Read article
By BOPA Committee on 12th July 2024

TRANScribing: Clinical considerations for safe and inclusive prescribing for transgender and non-binary patients

BOPA is delighted to announce the publication of TRANScribing: Clinical considerations for safe and inclusive prescribing for transgender and non-binary patients in collaboration with OUTpatients. It is estimated that one…

Read article
By BOPA Committee on 11th July 2024

Round Table Discussion at #BOPA2024

  As an exciting addition to the 2024 conference, we invite you all to participate in one of our interactive sessions on the Sunday morning. We have a lineup of…

Read article
By BOPA Committee on 10th July 2024

APTUK Position Statement for DHSC PGD Update

The Association of Pharmacy Technicians UK (APTUK), as the professional leadership body for pharmacy technicians, welcome the positive outcome of the DHSC consultation supporting the enabling of registered pharmacy technicians…

Read article